Data show no evidence of inhaled insulin-related lung cancer
Patients who received inhaled insulin using the AERx insulin Diabetes
Management System did not develop primary lung cancer, according to data
released by Aradigm Corporation.
Novo Nordisk, Aradigms partner in the development of the inhaled
insulin, conducted a review of...
FULL STORY